PRIMECAP MANAGEMENT CO/CA/
Institutional investor · Portfolio as of Q1 2020
Top Holdings296 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
ELI LILLY & CO | 41.9M | $5.8B | 5.7% | $104.89 | +23.08% | 6 qtrssince 2018-Q4 | Decreased 0 |
BIOGEN IDEC INC | 16M | $5.1B | 5.0% | $294.76 | +7.25% | 6 qtrssince 2018-Q4 | Increased 62 |
MICROSOFT CORP | 25.7M | $4.1B | 4.0% | $93.93 | +62.41% | 6 qtrssince 2018-Q4 | Decreased 0 |
ADOBE INC | 12.5M | $4B | 3.9% | $226.24 | +40.66% | 6 qtrssince 2018-Q4 | Decreased 0 |
AMGEN INC | 18.5M | $3.7B | 3.7% | $153.26 | +13.11% | 6 qtrssince 2018-Q4 | Increased 59 |
TEXAS INSTRUMENTS INC | 28.3M | $2.8B | 2.8% | $76.19 | +9.50% | 6 qtrssince 2018-Q4 | Decreased 0 |
ALIBABA GROUP HOLDING-SP ADR | 13.8M | $2.7B | 2.6% | $132.09 | +37.52% | 6 qtrssince 2018-Q4 | Decreased 0 |
ASTRAZENECA PLC | 56.6M | $2.5B | 2.5% | $62.04 | +24.47% | 6 qtrssince 2018-Q4 | Decreased 0 |
SOUTHWEST AIRLINES CO | 67.9M | $2.4B | 2.4% | $42.75 | -23.60% | 6 qtrssince 2018-Q4 | Decreased 0 |
MICRON TECHNOLOGY INC | 53.5M | $2.2B | 2.2% | $30.80 | +41.04% | 6 qtrssince 2018-Q4 | Decreased 0 |
SONY CORP-SPONSORED ADR | 35.1M | $2.1B | 2.0% | $9.23 | +26.44% | 6 qtrssince 2018-Q4 | Decreased 0 |
ALPHABET INC-CL A | 1.7M | $2B | 2.0% | $51.95 | +9.52% | 6 qtrssince 2018-Q4 | Decreased 0 |
NOVARTIS AG-SPONSORED ADR | 24M | $2B | 1.9% | $59.98 | +12.19% | 6 qtrssince 2018-Q4 | Decreased 0 |
ALPHABET INC-CL C | 1.5M | $1.8B | 1.8% | $51.47 | +10.57% | 6 qtrssince 2018-Q4 | Decreased 0 |
JPMORGAN CHASE & CO | 19.4M | $1.8B | 1.7% | $79.22 | +0.21% | 6 qtrssince 2018-Q4 | Decreased 0 |
FEDEX CORP | 13.7M | $1.7B | 1.6% | $140.04 | -20.16% | 6 qtrssince 2018-Q4 | Decreased 0 |
QUALCOMM INC | 23.4M | $1.6B | 1.6% | $48.04 | +26.81% | 6 qtrssince 2018-Q4 | Decreased 0 |
BIOMARIN PHARMACEUTICAL INC | 17.8M | $1.5B | 1.5% | $82.83 | -0.41% | 6 qtrssince 2018-Q4 | Increased 55 |
KLA CORP | 10.3M | $1.5B | 1.5% | $8.14 | +64.84% | 6 qtrssince 2018-Q4 | Increased 50 |
BOSTON SCIENTIFIC CORP | 42.3M | $1.4B | 1.4% | $34.69 | -8.78% | 6 qtrssince 2018-Q4 | Decreased 0 |
PRIMECAP MANAGEMENT CO/CA/ manages $102B across 296 positions as of Q1 2020. Top holdings: LLY (5.7%), BIIB (5.0%), MSFT (4.0%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 4.5/5.0.
Active quarter - 16 new positions, 13 exits, 79 increased. Top move: BIIB (INCREASED, conviction 62). Portfolio: $102.0B across 296 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer